Survival analyses from TCGA, Gene Expression Omnibus (GEO), and SYSU-FAH datasets consistently demonstrated that low AKR1B10 expression predicted poor outcomes in patients with CRC and GC (Fig. 1, K and L, and fig. This evidence concerns the gene AKR1B10 and gastric cancer.